Slentrol

RSS

Withdrawn

This medicine's authorisation has been withdrawn

dirlotapide
MedicineVeterinaryWithdrawn

Irish is available via eTranslation, the European Commission's machine translation service.

Translate to Irish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Slentrol has been withdrawn at the request of the marketing authorisation holder.

български (BG) (279.69 KB - PDF)

Amharc

español (ES) (239.85 KB - PDF)

Amharc

čeština (CS) (283.94 KB - PDF)

Amharc

dansk (DA) (239 KB - PDF)

Amharc

Deutsch (DE) (241.8 KB - PDF)

Amharc

eesti (ET) (237.14 KB - PDF)

Amharc

ελληνικά (EL) (282.67 KB - PDF)

Amharc

français (FR) (245.68 KB - PDF)

Amharc

italiano (IT) (238.08 KB - PDF)

Amharc

latviešu (LV) (283.06 KB - PDF)

Amharc

lietuvių (LT) (251.47 KB - PDF)

Amharc

magyar (HU) (253.42 KB - PDF)

Amharc

Malti (MT) (265.77 KB - PDF)

Amharc

Nederlands (NL) (217.72 KB - PDF)

Amharc

polski (PL) (282.55 KB - PDF)

Amharc

português (PT) (218.29 KB - PDF)

Amharc

română (RO) (242.81 KB - PDF)

Amharc

slovenčina (SK) (260.4 KB - PDF)

Amharc

slovenščina (SL) (252.65 KB - PDF)

Amharc

suomi (FI) (237.94 KB - PDF)

Amharc

svenska (SV) (239.22 KB - PDF)

Amharc

Product information

български (BG) (1.12 MB - PDF)

Amharc

español (ES) (413.23 KB - PDF)

Amharc

čeština (CS) (559.01 KB - PDF)

Amharc

dansk (DA) (619.26 KB - PDF)

Amharc

Deutsch (DE) (409.78 KB - PDF)

Amharc

eesti (ET) (394.94 KB - PDF)

Amharc

ελληνικά (EL) (1.78 MB - PDF)

Amharc

français (FR) (455.26 KB - PDF)

Amharc

italiano (IT) (432.39 KB - PDF)

Amharc

latviešu (LV) (543.86 KB - PDF)

Amharc

lietuvių (LT) (475.04 KB - PDF)

Amharc

magyar (HU) (577.53 KB - PDF)

Amharc

Malti (MT) (631.26 KB - PDF)

Amharc

Nederlands (NL) (419.67 KB - PDF)

Amharc

polski (PL) (601.64 KB - PDF)

Amharc

português (PT) (402.62 KB - PDF)

Amharc

română (RO) (490.98 KB - PDF)

Amharc

slovenčina (SK) (616.03 KB - PDF)

Amharc

slovenščina (SL) (568.91 KB - PDF)

Amharc

suomi (FI) (408.3 KB - PDF)

Amharc

svenska (SV) (413.86 KB - PDF)

Amharc

Íslenska (IS) (418.64 KB - PDF)

Amharc

norsk (NO) (405.73 KB - PDF)

Amharc
Latest procedure affecting product information:IAIN/0007/G
15/01/2015

български (BG) (202.54 KB - PDF)

Amharc

español (ES) (148.22 KB - PDF)

Amharc

čeština (CS) (192.56 KB - PDF)

Amharc

dansk (DA) (151.57 KB - PDF)

Amharc

Deutsch (DE) (152.17 KB - PDF)

Amharc

eesti (ET) (147.88 KB - PDF)

Amharc

ελληνικά (EL) (200.73 KB - PDF)

Amharc

français (FR) (474.14 KB - PDF)

Amharc

italiano (IT) (148.51 KB - PDF)

Amharc

latviešu (LV) (202.11 KB - PDF)

Amharc

lietuvių (LT) (191.42 KB - PDF)

Amharc

magyar (HU) (188.69 KB - PDF)

Amharc

Malti (MT) (194.75 KB - PDF)

Amharc

Nederlands (NL) (151.46 KB - PDF)

Amharc

polski (PL) (176.01 KB - PDF)

Amharc

português (PT) (151.81 KB - PDF)

Amharc

română (RO) (188.05 KB - PDF)

Amharc

slovenčina (SK) (195.92 KB - PDF)

Amharc

slovenščina (SL) (189.87 KB - PDF)

Amharc

suomi (FI) (147.96 KB - PDF)

Amharc

svenska (SV) (151.54 KB - PDF)

Amharc

Íslenska (IS) (151.76 KB - PDF)

Amharc

norsk (NO) (148.31 KB - PDF)

Amharc

Product details

Name of medicine
Slentrol
Active substance
dirlotapide
International non-proprietary name (INN) or common name
dirlotapide
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QA08AB91

Pharmacotherapeutic group

Antiobesity preparations, excl. diet products

Therapeutic indication

As an aid in the management of overweight and obesity in adult dogs. To be used as part of an overall weight-management programme that also includes appropriate dietary changes and exercise practice.

Authorisation details

EMA product number
EMEA/V/C/000116
Marketing authorisation holder
Zoetis Belgium SA

Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Marketing authorisation issued
13/04/2007
Revision
7

Assessment history

This page was last updated on

Share this page